[Can the risk of atrial fibrillation due to pulmonary embolism be minimized by addition of a platelet aggregation inhibitor to an oral anticoagulant?].
D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000209:etiology / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011655:Pulmonary Embolism / Q000150:complications*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
Is het risico van longembolie a.g.v. atriumfibrilleren te verkleinen door een trombocytenaggregatieremmer toe te voegen aan een oraal anticoagulans?